In the past few decades, the field of cancer treatment has undergone tremendous changes. As scientists gain a deeper understanding of the immune system, tumor immunotherapy is gradually becoming a highly promising new anti-cancer treatment method. This article will take you in depth to understand the development history, principles, and latest advances of tumor immunotherapy, as well as how it reshapes the future of the cancer war.

1、The Development History of Tumor Immunotherapy

The history of tumor immunotherapy can be traced back to the early 20th century, when scientists discovered the inhibitory effect of the immune system on tumors. However, early exploration of tumor immunotherapy mainly focused on the study of non-specific immunostimulants, although some initial success was achieved, the effect was not significant. Until the 1990s, with the development of genetic engineering and cell engineering technology, research on tumor immunotherapy ushered in new breakthroughs. Scientists are beginning to attempt to use these techniques to activate and enhance the immune system's ability to attack tumors.

2、The principles of tumor immunotherapy

The basic principle of tumor immunotherapy is to use the immune system to recognize, attack, and clear tumor cells. Unlike traditional methods such as surgery, radiation therapy, and chemotherapy, tumor immunotherapy aims to mobilize the patient's own immune system to fight cancer. By activating and enhancing the anti-tumor activity of immune cells, tumor immunotherapy can more accurately target cancer cells and reduce damage to normal cells.

3、The latest progress in tumor immunotherapy

In recent years, with the rapid development of immunotherapy, many new tumor immunotherapy methods have entered the clinical trial stage and achieved significant results. Among them, the most representative treatment methods include:

1. Immune checkpoint inhibitors: Immune checkpoint inhibitors are important drugs in tumor immunotherapy, which block the inhibitory signals released by tumor cells, alleviate the inhibitory effect on T cells, and enable them to re recognize and attack tumor cells. At present, immune checkpoint inhibitors such as PD-1 inhibitors and CTLA-4 inhibitors have been approved for various cancers and have become one of the main treatment methods for many patients.

2. Cancer vaccine: Cancer vaccine is another type of tumor immunotherapy that stimulates the immune system to produce immunity against specific cancers. At present, several cancer vaccines have been approved for clinical treatment, such as preventive cervical cancer vaccines and melanoma vaccines. These vaccines can prevent certain types of cancer or serve as adjunctive treatments for patients who have already contracted cancer.

3. Cell therapy: Cell therapy is a method of treating cancer using autologous or allogeneic cells, among which CAR-T cell therapy is one of the most representative cell therapies. CAR-T cell therapy has achieved significant results in the treatment of certain refractory leukemia by recognizing and attacking tumor cells through genetically engineered T cells. At present, this therapy is undergoing clinical trials in other types of cancer and is expected to be more widely applied in the future.

4. Immune cell therapy: In addition to CAR-T cell therapy, there are many other immune cell therapy methods under study. For example, natural killer cell therapy and macrophage therapy enhance the immune system's ability to attack cancer by stimulating or regulating it.

5. Combination therapy strategy: Currently, many clinical studies are exploring the combination of immunotherapy with other treatment methods, such as chemotherapy, radiotherapy, and targeted therapy. This combination therapy strategy aims to improve efficacy and reduce the occurrence of drug resistance through the synergistic effect of different mechanisms.

6. Precision immunotherapy: With the deepening of genomics and immunohistochemistry research, precision immunotherapy has become an emerging treatment strategy. This method analyzes the genetic and immune status of patients, develops personalized treatment plans to improve efficacy and reduce side effects. At present, precision immunotherapy is still in the research stage, but it is expected to become one of the mainstream treatment methods in the future.

4、Future prospects of tumor immunotherapy

Despite significant achievements in tumor immunotherapy, there are still many challenges and unknown areas that require further research and exploration. In the future, scientists will focus on the following areas of development:

1. Exploration of innovative targets and therapies: With a deeper understanding of the interaction mechanism between tumors and the immune system, more innovative targets and treatment methods will be discovered. For example, drugs targeting new targets, such as TIGIT and OX40, are currently undergoing clinical trials, and in the future, these drugs targeting new targets may greatly supplement existing immunotherapies.

2. Combination therapy strategy: The use of a single type of drug has various limitations, so combination therapy will become a development trend. Clinical studies have shown that combining PD-1/PD-L1 antibodies with chemotherapy drugs or other types of immunotherapy can significantly improve treatment outcomes. The synergistic effects between different drugs or treatment methods can more effectively combat cancer.

3. Personalized precision therapy: With the development of genomics, proteomics, and immunology, more personalized treatment plans will be developed based on individual differences of patients in the future. By comprehensively evaluating the patient's gene, protein expression, and immune status, the most suitable treatment plan is selected to improve treatment effectiveness and reduce side effects.

4. Overcoming drug resistance: Currently, many patients may experience drug resistance issues after using immunotherapy. Therefore, it is necessary to continue studying the mechanisms by which tumor cells develop resistance to immunotherapy, and to develop new drugs and methods to overcome resistance and improve treatment effectiveness.

5. Expand application scope: With the continuous progress of technology and in-depth research, the application scope of tumor immunotherapy may be further expanded to treat more types of cancer and other diseases. For example, some studies have explored the application of tumor immunotherapy in the treatment of other types of cancer, such as non-small cell lung cancer and colorectal cancer.

6. Cost reduction: Although tumor immunotherapy has shown great potential in many aspects, its high cost makes it difficult for many patients to obtain this treatment method. Therefore, in the future, efforts need to be made to optimize production processes, reduce costs, and promote the formulation and implementation of relevant policies, so that more patients can benefit from this advanced treatment method.

In summary, tumor immunotherapy as a new line of defense against cancer has shown great potential and hope. With the emergence of the Beacon single-cell photoconductive system from Redbert (Beijing) Biotechnology Co., Ltd., you can save a lot of time and greatly reduce production costs. The Beacon single-cell photoconductive system can intervene when the cell diversity and survival rate reach their optimal level after transfection, and it is easy to screen multiple cells and select cell lines with higher expression levels, greatly reducing subsequent production costs. The emergence of Beacon single-cell photoconductive system has made breakthrough progress in tumor immunotherapy, and it is believed that tumor immunotherapy will bring more breakthroughs and surprises for humans to overcome cancer.

* The above content is collected online for reference only. If the article on this website involves copyright or other issues, please contact us in a timely manner and we will handle it as soon as possible!